Dr. Jung-Mo Ahn, associate professor of chemistry at The University of Texas at Dallas, has designed and synthesized a novel small molecule that might become a large weapon in the fight against prostate cancer.
29 May, 2013
Manchester, Birmingham & Oxford, UK May 2013 – Cytox Limited, a UK company developing diagnostic and prognostic services for Alzheimer’s disease, announces the publication of new data using its blood-based phenoTOR™ assay technology. The data demonstrate the ability of the phenoTOR assay technology to assess the functional integrity of the mTOR pathway through analysis of lymphocytes and the relationship between this pathway and the development of Alzheimer’s disease pathology. The paper, published in Acta Neuropathologica Communications1, supports the development of the assay in the assessment of Alzheimer’s disease risk in patients.
24 May, 2013
A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side effects may be impossible to avoid. The study also found that the fundamental biochemical processes needed for life could have been enabled by the simple physics of protein folding.
21 May, 2013
You know that summer is here when juicy red strawberries start to appear on the shelves. In Germany, this seasonal fruit has never been more popular: on average 3.5 kilos per head were consumed in 2012 – a full kilogram more than ten years ago. Scientists from the Technische Universität München (TUM) decided to find out what gives strawberries their characteristic flavor.
13 May, 2013
How do researchers know whether new molecules will have a positive or negative effect? How much does the technique for moving a liquid affect the results? What about testing compounds for their environmental or health impacts: Is one liquid handling process better than another when it comes to accuracy of the data?
04 May, 2013
A new genetic profiling laboratory that will pioneer a quick and cost-effective new tumour test will give doctors a better chance of identifying the right treatment for UK cancer patients and increase access to clinical trials for the latest therapies.
02 May, 2013
Candidates will benefit from MRC Technology’s technology transfer knowledge and experience
01 May, 2013